Carbohydrate-rich diet for acute intermittent porphyria
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This trial tests whether a diet high in carbohydrates can help treat acute intermittent porphyria (AIP), a condition that can cause attacks of pain and other symptoms. If you have AIP, this study wants to see if eating more carbs can prevent or manage attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute intermittent porphyria (AIP).
- You are 18 years old or older.
- You are not pregnant.
- You do not have diabetes.
- You are not taking part in any other clinical research for AIP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find genes that may affect acute intermittent porphyria (AIP), a rare genetic condition that can cause sudden, severe attacks. By studying blood, saliva, and urine from family members, researchers hope to better understand and possibly improve treatment for this condition.
This study follows people with porphyria over time to learn more about the disease, its symptoms, and how it affects daily life. By tracking patients, researchers hope to improve care and understanding of this rare group of conditions.
This study is a registry (a list) of people diagnosed with acute hepatic porphyria. It helps researchers learn about the condition and track health information over time; it doesn’t test a new drug in the way treatment trials do.
This trial compares giving patients with mild or moderate acute pancreatitis an early carbohydrate drink versus a clear liquid diet. It aims to see which approach helps patients recover faster and better.
This trial studies a treatment to prevent recurrence in people with type 1 autoimmune pancreatitis (AIP) who are at high risk. It looks at how well the treatment works and whether it can keep the disease from coming back.
This trial tests if pirfenidone, an anti-scarring drug, can reduce the number of repeat episodes of acute pancreatitis. You may be eligible if you've had two or more pancreatitis attacks at least three months apart and are not having an active attack right now.
Hear when a new Porphyria, Acute Intermittent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.